Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis <scp>C</scp> patientsLuisa Ronzoni, Maria Domenica Cappellini, Alessio Aghemo et al.|Journal of Viral Hepatitis|2013Cited by 11
OC7 AN IL28B POLYMORPHISM PREDICTS PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 4Stella De Nicola, M. Colombo, G.M. Prati et al.|Digestive and Liver Disease|2011Cited by 10
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis CMaria Grazia Rumi, G.M. Prati, Alessio Aghemo|Journal of Viral Hepatitis|2012Cited by 7
291 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDYG.M. Prati, M. Colombo, Maria Grazia Rumi et al.|Journal of Hepatology|2010Cited by 4
Predictors of Psychopathological Outcome During Peg-Interferon and Ribavirin Therapy in Patients with Chronic HCV-Correlated HepatitisBernardo Dell’Osso, A.C. Altamura, G.M. Prati et al.|Journal of Interferon & Cytokine Research|2012Cited by 3